Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
) May Sell $10 Billion Plastics Unit To Focus On Health
4/29/2014 8:43:02 AM
Bayer AG’s top executive Monday declined to comment on reports the German company is exploring a sale of its material sciences segment, which has its North American headquarters in Robinson. In an interview broadcast on CNBC after the drug and chemicals giant released its first-quarter earnings, Marijn Dekkers, chief executive of Bayer said, “I don’t want to speculate on portfolio changes.” Bloomberg News reported Monday that Bayer is considering selling off the material sciences unit — which produces plastics, coatings and chemicals used in foams, insulation, auto lights and DVDs — because it wants to focus on expanding its health care business.
Help employers find you! Check out all the
post your resume
UK Cost Agency Says "No" To
(BAYN.DE) Prostate Cancer Drug Xofigo
Job Seekers Take Notice: Pharma Megamergers Could Be Back
(BAYN.DE) To Inject $700 Million In Hemophilia A Drugs
Roche Molecular Systems, Inc.
Approval For First Ever Pap Alternative To Detect Cervical Cancer
(BAYN.DE) Initiates Phase 3 Trial Of Xofigo® (Radium Ra 223 Dichloride) Injection In Combination With Abiraterone Acetate For Asymptomatic Or Mildly Symptomatic Chemotherapy-Naive Patients With Bone Predominant Metastatic Castration-Resistant Prostate Cancer
Calif. Biotech Firm
Moving To Georgia, Creating 80 Jobs
Dihon Pharmaceutical Group
For About $680 Million To Add Traditional Chinese Medicine To Product Line
(QTNTU) IPO Opens Flat, Moves Even Lower
(BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs
Forest Laboratories, Inc.
Furiex Pharmaceuticals, Inc.
(FURX) For $1.1 Billion Cash
comments powered by Disqus.
comments powered by
Biotech/Pharma - Mergers and Acquisitions
Medical Dev. & Diag. - Mergers and Acquisitions
Biotech/Pharma - Mergers and Acquisitions (World)